Natixis’s EyePoint Inc EYPT Stock Holding History

Natixis’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	+8,403	New	+$112K	﹤0.01%	983
2024 Q1	–	Sell	-2,500	Closed	-$57.8K	–	1076
2023 Q4	$57.8K	Buy	+2,500	New	+$27.9K	﹤0.01%	810

Other funds holding EYPT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Natixis's EYPT Position: Q2 2026 in Review

Natixis opened a new position in EyePoint Inc (EYPT) in Q2 2026: 8,403 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #983 among its holdings. This is a return to the name: Natixis previously reported a position in EYPT as recently as Q4 2023.

Natixis first reported a position in EYPT in Q4 2023 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

Natixis held 8,403 shares of EyePoint Inc worth $120K as of Q2 2026.
EyePoint Inc was a new Natixis position in Q2 2026.
EyePoint Inc made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #983 holding.
Natixis first reported a position in EyePoint Inc in Q4 2023 and has held it in 2 quarters since.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.